Browse the evidence

Moderate-intensity lifestyle counseling delivered by primary care clinicians and lifestyle coaches yields negligible net weight loss (~1.3 kg) over 24 months, primarily due to significant weight rebound after the initial 12 months when coaching frequency is tapered.

If you are relying on a primary care weight loss program that involves seeing a coach monthly for a year and then less frequently, do not expect significant long-term weight loss. This study shows that such moderate-intensity interventions result in negligible weight change (~1.3 kg) and often a rebound after the first year. To achieve meaningful weight loss, you likely need more intensive, frequent, or specialized interventions than standard primary care counseling provides.

Enhanced care interventions (physician letter, personalized chart, and registered dietitian counseling) do not significantly improve gestational weight gain outcomes compared to usual care in the aggregate population of women with pregestational obesity.

For pregnant women with obesity, adding intensive lifestyle interventions (dietitian visits, personalized charts, physician letters) to standard care does not significantly improve overall gestational weight gain outcomes compared to standard care alone. However, this lack of benefit is driven by Class I and II obesity patients who do well with standard care; Class III obesity patients specifically benefit from the enhanced intervention.

Women with Class I or Class II obesity achieve better gestational weight gain outcomes with usual care compared to enhanced care interventions.

For pregnant women with Class I or II obesity, standard obstetric care and written educational materials are sufficient to achieve healthy weight gain. Adding intensive lifestyle interventions (dietitian visits, personalized charts) does not improve outcomes and may be unnecessary resource expenditure for these patients.

Body weight stigma acts as a significant barrier to healthcare engagement and long-term weight management success.

If you feel judged by healthcare providers, it is a common and valid experience that can hinder your care. Seek out providers who practice weight-inclusive or stigma-informed care. Addressing the psychological burden of stigma is a crucial part of effective obesity management.

Systematic health system protocols, including consistent diagnosis and electronic health record decision support, are required to effectively treat early metabolic disease and prevent progression to advanced diabetes and cardiovascular disease.

Health systems should implement protocols to consistently diagnose and treat early metabolic disease. This includes using electronic health records to flag at-risk patients and providing decision support for lifestyle, medication, or surgery referrals. This systematic approach improves outcomes and reduces long-term healthcare costs.

Initial patient engagement by cardiologists must be handled with discretion, sensitivity, and non-judgmental communication to avoid reinforcing stigma and alienation, which negatively impact quality of care.

If you are overweight, expect your doctor to be respectful and non-judgmental. If you feel judged, it is okay to express your concerns. A good doctor will listen and work with you at your pace.

The 'obesity paradox' in heart failure—where overweight/obese patients have better short-term outcomes than normal-weight patients—is likely confounded by unintentional weight loss from underlying diseases (like cancer) and lead-time bias, rather than being a true protective effect of obesity.

Do not rely on the 'obesity paradox' to avoid weight management. The idea that being overweight helps heart failure is likely a statistical error caused by sick people losing weight unintentionally. Intentional weight loss is associated with better clinical outcomes.

Providing free, convenient gym access to employees does not significantly improve weight loss outcomes compared to standard behavioral interventions, as gym usage remains low and weight loss is driven by the behavioral program rather than facility proximity.

Buying a gym membership or working near a gym will not automatically make you lose weight. In this study, people who worked near the gym used it more often, but they didn't lose more weight than those who didn't. Weight loss came from the behavioral program (diet/lifestyle coaching), not the gym access itself. Focus on the behavioral changes (diet, activity habits) rather than just buying access to facilities.

Current herbal anti-obesity clinical trials frequently fail to adhere to international pharmaceutical guidelines, particularly regarding study duration, lifestyle modifications, and safety monitoring.

When evaluating herbal weight loss studies, be aware that many do not follow the same rigorous standards as pharmaceutical trials. Look for studies that include lifestyle modifications, adequate duration, and safety monitoring, as these are often missing.

Off-label use of GLP-1 agonists by healthy athletes for aesthetic or performance purposes raises ethical, legal, and safety concerns, including potential classification as doping and inequality in sports access.

Using GLP-1 agonists off-label for aesthetic or performance reasons is not approved and carries ethical and legal risks. It may be viewed as doping and creates inequality in sports. Athletes should consult regulatory bodies and prioritize approved medical indications over off-label use for performance enhancement.

The Nutri-Score front-of-pack labeling system fails to identify unhealthy ultra-processed foods because it evaluates only nutrient composition and ignores the degree of food processing.

Do not rely solely on the Nutri-Score letter (A-E) to judge if a food is healthy. A product can receive an 'A' rating for nutrients but still be an ultra-processed food (NOVA 4) with additives and low nutritional value in terms of food matrix. Look for the degree of processing (NOVA classification) alongside or instead of Nutri-Score to make better choices.

A 6-month produce prescription program providing $60/month in vouchers for fruit and vegetables does not significantly improve glycemic control (HbA1c), blood pressure, or BMI in patients with diabetes compared to usual care.

For patients with diabetes, simply receiving vouchers for fruit and vegetables is not enough to lower blood sugar. To see health benefits, programs must ensure the voucher amount is sufficient for the patient's household size and include robust, ongoing nutritional education. Without these supports, financial incentives alone may fail to improve clinical outcomes.

The long-term mental health and quality of life benefits of an intensive lifestyle intervention (ILI) for type 2 diabetes do not persist after the intervention is terminated; participants revert to baseline risk levels comparable to a control group.

If you stop the structured support of a lifestyle program, your mental health and quality of life benefits will likely erate over time, even if you maintain some weight loss. To keep the psychological benefits, you need a long-term maintenance plan, not just an initial intensive phase.

Smoking is a significant risk factor that increases the risk of incident symptomatic peripheral arterial disease in individuals with diabetes mellitus.

If you smoke, quitting is critical for preventing peripheral arterial disease, especially if you have diabetes. This study shows that smokers have nearly twice the risk of developing PAD compared to non-smokers. Stopping smoking is the most impactful lifestyle change you can make to protect your circulation.

Standard, unvalidated diet quality (HEI-C) and fitness measures fail to correlate with clinical metabolic syndrome reversal, whereas factor-analytically derived latent models of these constructs demonstrate excellent measurement equivalence and validity.

If you are tracking diet or fitness progress to manage metabolic health, standard off-the-shelf scores (like basic HEI-C) may not accurately reflect your clinical improvements. To truly link your lifestyle changes to health outcomes, use validated, multi-component assessments that account for measurement error, rather than relying on single, unvalidated metrics.

The COVID-19 pandemic and associated mitigation strategies (e.g., stay-at-home orders, physical distancing) caused a significant increase in the prevalence of depressive symptoms and loneliness among older adults with type 2 diabetes, while insomnia prevalence remained stable.

If you are an older adult with diabetes, be aware that pandemic-related isolation can significantly worsen mood and loneliness. Monitor your mental health closely, as the risk is higher if you had prior symptoms. Prioritize safe social engagement strategies to mitigate these effects.

Obesity is a stigmatized condition where the desire for cosmetic weight loss often exceeds the desire for health benefits, leading to a mismatch between patient expectations and clinical outcomes, which negatively affects treatment adherence and drug regulation.

Understand that your desire to look different is normal, but clinical weight loss is slow and modest. Health benefits happen at lower weight loss levels than cosmetic changes. Focus on how you feel and your health markers (blood pressure, blood sugar) rather than just the scale number to stay motivated.

Health-related stigma acts as a global barrier that impedes health-seeking behavior, engagement in care, and adherence to treatment across various conditions.

Health stigma is a major, documented barrier to getting care and sticking to treatment plans. It operates through social, cultural, and structural forces, not just individual psychology. To improve health outcomes, interventions must address these multi-level drivers rather than focusing solely on individual coping.

High levels of physical activity are associated with a 27% increased risk of melanoma, likely due to increased outdoor sun exposure rather than the activity itself.

If you exercise outdoors, prioritize sun safety. Use sunscreen, wear protective clothing, and seek shade when possible to mitigate the increased risk of melanoma associated with outdoor physical activity.

The prevalence of Metabolic Syndrome in the Asia-Pacific region is increasing over time (secular trends) in countries like China, South Korea, and Taiwan.

Metabolic Syndrome rates are rising in China, South Korea, and Taiwan. This trend is driven by lifestyle changes, so focusing on diet and exercise is crucial to prevent further increases.

Weight stigma in healthcare settings leads to poorer quality of care, delayed medical attention, and worse health outcomes for patients with obesity.

If you have obesity, advocate for your health by seeking providers who focus on behaviors and metabolic markers rather than just weight. If you feel dismissed or stigmatized, seek a second opinion. Healthcare providers should be trained to recognize and mitigate their own biases to ensure equitable care.

Stepping intensity (cadence) is not independently associated with lower mortality rates after accounting for total step volume.

You do not need to walk fast to reduce your risk of death. Focus on increasing your total number of steps. If you walk slowly, that still counts toward your daily goal. The benefit comes from the volume of steps, not how fast you take them.

Poor social engagement (including poor social network and poor social support) is associated with a significantly increased risk of developing dementia.

Prioritize building and maintaining a reliable social network and seeking social support, as these structural aspects of socialization are linked to a lower risk of dementia. Focus on objective measures like having a close friend, regular contact, and support systems rather than just subjective feelings of loneliness, which showed less consistent protective effects in this analysis.

Integration of food and nutrition into healthcare systems requires sustainable funding, clinician education, and rigorous research to be effective and scalable.

Advocate for your healthcare system to integrate food interventions. This means pushing for sustainable funding, better clinician nutrition education, and rigorous research to ensure these programs are effective and accessible.